Daily news
Using evidence as the guiding star, the @ducrest Twitter timeline consists of the latest scientific publications in dermatology, cosmetic dermatology, cosmetics and Home-Use devices. Here you will find interesting information gleaned from science and technology sources as well as the lay press.
Alphyn Biologics and AB-101!
AB-101 first target disease is Atopic Dermatitis & is expected to treat all AD associa…
https://twitter.com/i/web/status/1526083276858970115
@itchdoctor @filierefimarad @ichtyosefrance @fdmaladiesrares @AADskin @eadv @aedv_es I guess yes. I will leave it t…
https://twitter.com/i/web/status/1525449456786849794
@filierefimarad @ichtyosefrance @fdmaladiesrares @AADskin @eadv @aedv_es @itchdoctor FYI @IADPO @francepeau…
https://twitter.com/i/web/status/1525425126023610369
RT @ducrest: @filierefimarad #skin #raredisease
@filierefimarad launches the Call for Research Projects to select & finance specific projec…
@filierefimarad #skin #raredisease
@filierefimarad launches the Call for Research Projects to select & finance spec…
https://twitter.com/i/web/status/1525424250454265856
RT @riddmj: Great impact from the BATHE study which found that emollient bath additives provide minimal or no additional benefit beyond sta…
RT @ducrest: Healing Skin in Kenya – consider donating! Check out my latest article.
linkedin.com/pulse/healing-… via @LinkedIn
Sources: Thanks…
RT @ducrest: Support Dermatology in Tanzania – virtual educational supervisors! This #dermatology training centre in Moshi has recently acc…
RT @ducrest: @rihanna @fentybeauty @fentyskin Fenty Beauty and Fenty Skin into Africa. Improving access to care is paramount. Promoting acc…
@rihanna @fentybeauty @fentyskin Fenty Beauty and Fenty Skin into Africa. Improving access to care is paramount. Pr…
https://twitter.com/i/web/status/1525158189896974336